NGFN Facts and Figures
4. Patents from NGFN-1, NGFN-2, NGFN-Plus and NGFN-Transfer
Taking the fast lane from research to utilization
The application of research results from NGFN-Plus and NGFN-Transfer is an important aim of the Program of Medical Genome Research. A crucial step for the practical application is the filing of patents for protectable inventions and developments. Therefore the number of patents is a measure for the utilization of NGFN research.
The diagram shows the number of patents granted in the respective funding periods of NGFN. For the current reporting period all 43 filed patents were counted.
Patent number: EP09014856.0
Title: A method for diagnosing metabolic syndrome, obesity and/or diabetes
Inventor: Schürmann-Bartsch, Scherneck, Vogel, Joost
Applicant: Deutsches Institut für Ernährungsforschung
State: withdrawn; Priority date: 30.11.2009
Patent number: EP12161060.4/ US 61/814,758 (Together with Genome Network
DiGtoP)
Title: A novel method of producing an oocyte carrying a modified target sequence in
its genome
Inventor: Kühn, Wurst, Meyer
Applicant: Helmholtz Zentrum München
State: Patent application filed and technology in commercial exploitation;
Priority date: 23.03.2012
Patent number: EP13153142.8
Title: Foam cell specific Liver X Receptor (LXR) alpha agonist, SIRT1 inhibitors as well
as p300 inhibitors as pharmaceutically active agents
Inventor: S. Sauer, S. Holzhauser, R. Feldmann, A. Geikowski
Applicant: Max-Planck-Gesellschaft;
Priority date: 29.1.2013
Patent number: EP13165716.5
Title: PPARgamma Modulators
Inventor: S. Sauer. C. Weidner, M. Kliem
Applicant: Max-Planck-Gesellschaft, Priority date: 29.4.2013
Genome Network Heart Failure
Patent number: US61/219,125
Title: Polynucleotides for diagnostic and prognostic of a cardiac disease
Inventor: Gotthardt, Hübner, Graeser, Guo
Applicant: MDC Berlin
State: Patent application filed and technology in commercial exploitation;
Priority date: 22.06.2009
Genome Network Herpes virus infection
Patent number: EP11002480
Title: Micro RNA Inhibiting Nucleic Acid Molecule
Inventor: Lars Dölken, Ulrich Koszinowski, Sebastien Pfeffer
Applicant: Lars Dölken, LMU München
State: Released to the inventor; Priority date: 24.03.2011
Patent number: EP11306102.2
Title: MicroRNAs from human herpesvirus 6
Inventor: Lars Dölken, Sebastien Pfeffer, Lee Tuddenham, Jette Jung
Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
State: Pending; Priority date: 06.09.2011
Genome Network Pancreatic Cancer
Patent number: EP10001596.5
Title: Means and methods for diagnosing pancreatic cancer
Inventor: Christoph Schröder, Jörg Hoheisel, Tatjana Crnogorac-Jurcevic
Applicant: DKFZ Heidelberg
State: Pending; Priority date: 17.02.2010
Patent number: EP11169588.8
Title: Prediction of recurrence for superficial bladder cancer by protein signature in
tissue samples
Inventor: Hoheisel, Radvanyi, Srinivasan, Schröder
Applicant: DKFZ und Institut Curie
State: Pending; Priority date: 10.06.2011
Patent number: US61/536,486
Title: Methods and composition involving miR-135b for distinguishing pancreatic
cancer from benign pancreatic disease
Inventor: Alex Adai, Anna Szafranska-Schwarzbach, Bernard Andruss, Stephan
Albrecht Hahn Applicant: Universität Bochum, ASURAGEN
State: Released; Priority date: 19.09.2011
Patent number: DE102011108254.2; DE102012005153.0
Title: Pantumormarker II (snRNA RNU2-1 as a tumor marker)
Inventor: A. Baraniskin, S. Hahn, W. Schmiegel
Applicant: Universität Bochum
State: Patent application filed and technology in commercial exploitation;
Priority date: 16.03.2012
Genome Network Brain Tumor
Patent number: EP09006620.0
Title: Diagnostic methods for the prognosis of a brain tumor
Inventor: von Deimling, Hartmann, Zentgraf, Reifenberger, Capper, Weller, Wick
Applicant: DKFZ, Ruprecht-Karls-Universität Heidelberg
State: Pending; Priority date: 15.05.2009
Patent number: US61/334,812
Title: Methods for the diagnosis and prognosis of a tumor using BCAT1 protein
Inventor: Radlwimmer, Barbus, Tönjes, Tödt, Lichter, Reifenberger
Applicant: DKFZ Heidelberg
State: Pending; Priority date: 14.05.2010
Patent number: EP11000720.0
Title: Inhibitors of branched-chain-aminotransferase-1 (BCAT1) for the treatment of
neoplasia
Inventor: Bernhard Radlwimmer, Sebastian Barbus, Martje Tönjes, Peter Lichter
Applicant: DKFZ
State: Pending; Priority date: 28.01.2011
Patent number: US61/388,158; US61/503,950
Title: Means and methods for diagnosing cancer using an antibody which specifically
binds to BRAF V600E
Inventor: von Deimling, Capper
Applicant: DKFZ, Ruprecht-Karls-Universität Heidelberg
State: Patent application filed and technology in commercial exploitation;
Priority date: 30.09.2010; 01.07.2011
Genome Network Leukemia
Patent number: EP10004898.2
Title: Risk prognosis method for chronic lymphocytic leukemia
Inventor: Herold, Jurinovic, Buske, Bohlander
Applicant: Ludwig-Maximilians-Universität München
State: Pending; Priority date: 07.05.2010
Genome Network Mutanom
Patent number: EP09158709.7
Title: Use of MLKL in cancer therapy
Inventor: Mollenhauer, Hudler, Blaich, Wittig
Applicant: DKFZ
State: Pending; Priority date: 24.04.2009
Genome Network Neuroblastoma
Patent number: DE102010024300.0 / DE102010024512.7
Title: Neue Ansätze für die Tumortherapie-Histondemethylasen
Inventor: PD Dr. Alexander Schramm, Dr. Johannes Schulte, Prof. Dr. Angelika Eggert
Applicant: Universität Duisburg-Essen
State: Released by ProVendis: Priority date: 21.06.2010
Genome Network Cancer Genes
Patent number: EP09005492.5; US61/170,375
Title: Development of fluorescently P-loop labeled kinases for screening of inhibitors
Inventor: Rauh, Daniel; Simard, Jeffrey
Applicant: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.,
Hofgartenstr. 8, 80539 München
State: Pending; Priority date: 17.04.2009
Patent number: EP08013340.8; US61/083,335; EP08020331.7; EP09005493.3
Title: Fluorescently or spin-labeled kinases for rapid screening and identification of
novel kinase inhibitor scaffolds
Inventor: Rauh, Daniel; Simard, Jeffrey; Getlik, Matthäus;
Applicant: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.,
Hofgartenstr. 8, 80539 München;
State: Pending; Priority date: 17.04.2009
Patent number: EP09177117.0
Title: Pyrosequencing method for predicting the response of a patient towards anti
cancer treatment, European Patent application
Inventor: Altmüller, Nürnberg, Querings
Applicant: Universität zu Köln
State: Pending; Priority date: 25.11.2009
Patent number: EP11164480.3
Title: Blood-based gene detection of non-small cell lung cancer
Inventor: Hofmann, Schultze, Staratschek-Jox, Wolf, Zander
Applicant: Rheinische Friedrich-Wilhelms-Universität Bonn, Universität zu Köln
State: Pending; Priority date: 02.05.2011
Patent number: US 61/529,476; EP11007082.8
Title: Labeled phosphatases for the screening of inhibitors
Inventor: Rauh, Daniel; Simard, Jeffrey; Waldmann, Herbert
Applicant: Max-Planck-Gesellschaft
Priority date: 31.08.2011
Patent number: EP12153907.6
Title: Novel fusion genes in lung cancer
Inventor: Thomas, Roman; Heuckmann, Johannes; Fischer, Florian; Fernandez-
Cuesta, Lynnette
Applicant: Max-Planck-Gesellschaft
State: Patent application filed and technology in commercial exploitation;
Priority date: 03.02.2012
Genome Network Prostate Cancer
Patent number: DE202009008601.1 (Together with Genome Network Cellular Systems
Genomics)
Title: Inkubationsschale für Hochdurchsatzverfahren bei Protein-Array-Inkubationen
(Gebrauchsmuster)
Inventor: Mannsperger, Schmidt, Korf, Fink, Kameke
Applicant: DKFZ; Metecon GmbH
State: Published; Priority date: 19.06.2009
Patent number: EP09174455.7
Title: Circulating miRNAs as non-invasive markers for diagnosis and staging in
prostate cancer
Inventor: Jan C. Brase, Marc Johannes, Thorsten Schlomm, Maria Fälth, Alexander
Haese, Thomas Steuber, Tim Beissbarth, Ruprecht Kuner, Holger Sültmann
Applicant: DKFZ und Uni Göttingen und Uniklinikum HH-Eppendorf
State: Pending; Priority date: 29.10.2009
Patent number: EP 11162979.6
Title: Epigenetische Marker zur Prostata-Tumor-Diagnostik (Prostate cancer markers)
Inventor: R. Schweiger, H. Lehrach, S. Börno, H. Sültmann, T. Schlomm, G. Sauter
Applicant: Max-Planck-Gesellschaft und DKFZ
State: Submitted; Priority date: 19.04.2011
Genome Network Colon Cancer
Patent number: EP12180459.5
Title: : Biomarkers for colon cancer
Inventor: Schweiger, Michal-Ruth; Grimm, Christina; Herwig, Ralf; Lehrach, Hans
Applicant: Max-Planck-Gesellschaft
Priority date: 14.08.2012
Genome Network Neurodegeneration
Patent number: EP11161325.3
Title: Phenoxazinones or phenothiazones as inhibitors of amyloid formation
Inventor: Wanker, Herbst, Bieschke, Wagner, Wiglenda, Schmidt, Böddrich
Applicant: MDC Berlin
State: Pending; Priority date: 06.04.2011
Genome Network Cellular Systems Genomics
Patent number: DE202009008601.1 (Together with Genome Network Prostate Cancer)
Title: Inkubationsschale für Hochdurchsatzverfahren bei Protein-Array-
Inkubationen (Gebrauchsmuster)
Inventor: Mannsperger, Schmidt, Korf, Fink, Kameke
Applicant: DKFZ; Metecon GmbH
State: Published; Priority date: 19.06.2009
Patent number: EP12154916.6
Title: Biomarker set for identifying a severe form of cancer
Inventor: Korf, Ulrike; Wiemann, Stefan; Bender, Christian; Sonntag, Johanna
Applicant: DKFZ; Priority date: 10.02.2012
Genome Network DiGtoP
Patent number: EP09014709.1, EP09014889.1, US61/264,514, US 61/265,296
Title: Conditional expression of transgenes in vivo
Inventor: L. Schebelle (HMGU), F. Schnütgen (Uni Frankfurt), T. Floss (HMGU)
Applicant: Helmholtz Zentrum München, Uni Frankfurt
State: Pending; Priority date: 25.11.2009; 30.11.2009; 01.12.2009
Patent number: US61/255,621
Title: Homologous recombination in the oocyte
Inventor: Ralf Kühn, Melanie Meyer, Wolfgang Wurst
Applicant: Ralf Kühn, Melanie Meyer, Wolfgang Wurst; Helmholtz Zentrum München
State: Pending; Priority date: 28.10.2009
Patent number: EP10005863.5/ US61/352,103
Title: Fusion proteins comprising a DNA-binding domain of a Tal effector protein and a
nonspecific cleavage domain of a restriction nuclease and their use
Inventor: Kühn, Wurst, Meyer
Applicant: Helmholtz Zentrum München
State: Pending; Priority date: 07.06.2010
Patent number: EP11004637.2
Title: Improved Recombination Efficiency by Inhibition of NHEJ DNA Repair
Inventor: Kühn, Wurst
Applicant: Helmholtz Zentrum München
State: Pending, Priority date: 07.06.2011
Patent number: EP11004635.6
Title: Protein having nuclease activity, fusion proteins and uses thereof
Inventor: Kühn
Applicant: Helmholtz Zentrum München
State: Pending, Priority date: 07.06.2011
Patent number: EP10009584.3; 13/823,431 / 10 009 584.3
Title: HOT1 and uses thereof
Inventor: Dr. D. Kappei, Prof. Dr. F. Buchholz, Prof. Dr. M. Mann, Dr. F. Butter
Applicant: Max-Planck-Innovation GmbH
State: Pending; Priority date: 14.09.2010
Patent number: EP12161060.4/ US 61/814,758 (Together with Genome Network
Obesity)
Title: A novel method of producing an oocyte carrying a modified target sequence in
its genome
Inventor: Kühn, Wurst, Meyer
Applicant: Helmholz Zentrum München
State: Patent application filed and technology in commercial exploitation;
Priority date: 23.03.2012
Patent number: EP131507063.2
Title: Gene editing in the oocyte by Crispr-Cas9 nucleases
Inventor: Kühn, Wurst, Ortiz
Applicant: Helmholtz Zentrum München
State: Pending; Priority date: 15.02.2013
Genome Network Environment-related Diseases
Patent number: PCT/EP2008/008491
Title: Method for identifying an increased susceptibility to ulcerative colitis
Inventor: Schreiber, Franke
Applicant: Universität Kiel
State: Pending, Priority date: 08.10.2008
Patent number: US61/113,342; EP09006623.4-2403
Title: X-chromosomal variation as a diagnostic and therapeutic marker for the
progression to AIDS
Inventor: Siddiqui, Roman; Sauermann, Ulrike; Altmüller, Janine; Nürnberg, Peter;
Fritzer, Elfriede; Nothnagel, Michael; Krawczak, Michael; Platzer, Mathias
Applicant: Deutsches Primatenzentrum GmbH; Leibniz-Institut für Altersforschung
Fritz-Lipmann-Institut e.V.; Universität zu Köln; Christian-Albrechts-Univ. zu Kiel
State: Pending; Priority date: 11.11.2008, 15.05.2009
Innovation Alliance Anti-malarial Agents
Patent number: US61/110,217
Title: Use of inhibitors of host kinases for the treatment of infectious diseases
Inventor: Hannus, Martin, Mota, Prudencio, Rodrigues
Applicant: Cenix BioScience GmbH, Instituto de Medicina Molecular, Faculdade de
Medicina da Universidade de Lisboa
State: Pending; Priority date: 31.10.2008
Innovation Alliance Metabolomic Signatures of Heart Failure
Patent number: US61/299,360; EP10000915.8
Title: Means and methods for diagnosing heart failure in a subject
Inventor: Fuhrmann, Reszka, Kastler, Busch, Leibold, Katus, Frey, Weis, Wolf
Applicant: Metanomics GmbH und Universität Heidelberg
State: Pending; Priority date: 29.01.2010
Innovation Alliance New Tools CVD
Patent number: EP09171773.6
Title: Vasoactive peptide and derivatives thereof
Inventor: Prof. Dr. J. Jankowski, Dr. V. Jankowski, Prof. Dr. W. Zidek, Dr. A. Kretschmer,
Prof. Dr. R. Santos, Prof. Dr. M. van der Giet
Applicant: Bayer Schering Pharma AG, Charité Universitätsmedizin Berlin
State: Pending; Priority date: 30.09.2009
Innovation Alliance WTA Amplification Methods for Biobanks
Patent number: DE102009024143.4
Title: Amplifikation komplexer Nukleinsäuren
Inventor: Korfhage, Fisch
Applicant: Qiagen GmbH
State: Pending; Priority date: 04.06.2009
Download this website as pdf
The application of research results from NGFN-Plus and NGFN-Transfer is an important aim of the Program of Medical Genome Research. A crucial step for the practical application is the filing of patents for protectable inventions and developments. Therefore the number of patents is a measure for the utilization of NGFN research.
The diagram shows the number of patents granted in the respective funding periods of NGFN. For the current reporting period all 43 filed patents were counted.
Patents of NGFN-Plus und NGFN-Transfer 2008 - 2013
Genome Network ObesityPatent number: EP09014856.0
Title: A method for diagnosing metabolic syndrome, obesity and/or diabetes
Inventor: Schürmann-Bartsch, Scherneck, Vogel, Joost
Applicant: Deutsches Institut für Ernährungsforschung
State: withdrawn; Priority date: 30.11.2009
Patent number: EP12161060.4/ US 61/814,758 (Together with Genome Network
DiGtoP)
Title: A novel method of producing an oocyte carrying a modified target sequence in
its genome
Inventor: Kühn, Wurst, Meyer
Applicant: Helmholtz Zentrum München
State: Patent application filed and technology in commercial exploitation;
Priority date: 23.03.2012
Patent number: EP13153142.8
Title: Foam cell specific Liver X Receptor (LXR) alpha agonist, SIRT1 inhibitors as well
as p300 inhibitors as pharmaceutically active agents
Inventor: S. Sauer, S. Holzhauser, R. Feldmann, A. Geikowski
Applicant: Max-Planck-Gesellschaft;
Priority date: 29.1.2013
Patent number: EP13165716.5
Title: PPARgamma Modulators
Inventor: S. Sauer. C. Weidner, M. Kliem
Applicant: Max-Planck-Gesellschaft, Priority date: 29.4.2013
Genome Network Heart Failure
Patent number: US61/219,125
Title: Polynucleotides for diagnostic and prognostic of a cardiac disease
Inventor: Gotthardt, Hübner, Graeser, Guo
Applicant: MDC Berlin
State: Patent application filed and technology in commercial exploitation;
Priority date: 22.06.2009
Genome Network Herpes virus infection
Patent number: EP11002480
Title: Micro RNA Inhibiting Nucleic Acid Molecule
Inventor: Lars Dölken, Ulrich Koszinowski, Sebastien Pfeffer
Applicant: Lars Dölken, LMU München
State: Released to the inventor; Priority date: 24.03.2011
Patent number: EP11306102.2
Title: MicroRNAs from human herpesvirus 6
Inventor: Lars Dölken, Sebastien Pfeffer, Lee Tuddenham, Jette Jung
Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
State: Pending; Priority date: 06.09.2011
Genome Network Pancreatic Cancer
Patent number: EP10001596.5
Title: Means and methods for diagnosing pancreatic cancer
Inventor: Christoph Schröder, Jörg Hoheisel, Tatjana Crnogorac-Jurcevic
Applicant: DKFZ Heidelberg
State: Pending; Priority date: 17.02.2010
Patent number: EP11169588.8
Title: Prediction of recurrence for superficial bladder cancer by protein signature in
tissue samples
Inventor: Hoheisel, Radvanyi, Srinivasan, Schröder
Applicant: DKFZ und Institut Curie
State: Pending; Priority date: 10.06.2011
Patent number: US61/536,486
Title: Methods and composition involving miR-135b for distinguishing pancreatic
cancer from benign pancreatic disease
Inventor: Alex Adai, Anna Szafranska-Schwarzbach, Bernard Andruss, Stephan
Albrecht Hahn Applicant: Universität Bochum, ASURAGEN
State: Released; Priority date: 19.09.2011
Patent number: DE102011108254.2; DE102012005153.0
Title: Pantumormarker II (snRNA RNU2-1 as a tumor marker)
Inventor: A. Baraniskin, S. Hahn, W. Schmiegel
Applicant: Universität Bochum
State: Patent application filed and technology in commercial exploitation;
Priority date: 16.03.2012
Genome Network Brain Tumor
Patent number: EP09006620.0
Title: Diagnostic methods for the prognosis of a brain tumor
Inventor: von Deimling, Hartmann, Zentgraf, Reifenberger, Capper, Weller, Wick
Applicant: DKFZ, Ruprecht-Karls-Universität Heidelberg
State: Pending; Priority date: 15.05.2009
Patent number: US61/334,812
Title: Methods for the diagnosis and prognosis of a tumor using BCAT1 protein
Inventor: Radlwimmer, Barbus, Tönjes, Tödt, Lichter, Reifenberger
Applicant: DKFZ Heidelberg
State: Pending; Priority date: 14.05.2010
Patent number: EP11000720.0
Title: Inhibitors of branched-chain-aminotransferase-1 (BCAT1) for the treatment of
neoplasia
Inventor: Bernhard Radlwimmer, Sebastian Barbus, Martje Tönjes, Peter Lichter
Applicant: DKFZ
State: Pending; Priority date: 28.01.2011
Patent number: US61/388,158; US61/503,950
Title: Means and methods for diagnosing cancer using an antibody which specifically
binds to BRAF V600E
Inventor: von Deimling, Capper
Applicant: DKFZ, Ruprecht-Karls-Universität Heidelberg
State: Patent application filed and technology in commercial exploitation;
Priority date: 30.09.2010; 01.07.2011
Genome Network Leukemia
Patent number: EP10004898.2
Title: Risk prognosis method for chronic lymphocytic leukemia
Inventor: Herold, Jurinovic, Buske, Bohlander
Applicant: Ludwig-Maximilians-Universität München
State: Pending; Priority date: 07.05.2010
Genome Network Mutanom
Patent number: EP09158709.7
Title: Use of MLKL in cancer therapy
Inventor: Mollenhauer, Hudler, Blaich, Wittig
Applicant: DKFZ
State: Pending; Priority date: 24.04.2009
Genome Network Neuroblastoma
Patent number: DE102010024300.0 / DE102010024512.7
Title: Neue Ansätze für die Tumortherapie-Histondemethylasen
Inventor: PD Dr. Alexander Schramm, Dr. Johannes Schulte, Prof. Dr. Angelika Eggert
Applicant: Universität Duisburg-Essen
State: Released by ProVendis: Priority date: 21.06.2010
Genome Network Cancer Genes
Patent number: EP09005492.5; US61/170,375
Title: Development of fluorescently P-loop labeled kinases for screening of inhibitors
Inventor: Rauh, Daniel; Simard, Jeffrey
Applicant: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.,
Hofgartenstr. 8, 80539 München
State: Pending; Priority date: 17.04.2009
Patent number: EP08013340.8; US61/083,335; EP08020331.7; EP09005493.3
Title: Fluorescently or spin-labeled kinases for rapid screening and identification of
novel kinase inhibitor scaffolds
Inventor: Rauh, Daniel; Simard, Jeffrey; Getlik, Matthäus;
Applicant: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.,
Hofgartenstr. 8, 80539 München;
State: Pending; Priority date: 17.04.2009
Patent number: EP09177117.0
Title: Pyrosequencing method for predicting the response of a patient towards anti
cancer treatment, European Patent application
Inventor: Altmüller, Nürnberg, Querings
Applicant: Universität zu Köln
State: Pending; Priority date: 25.11.2009
Patent number: EP11164480.3
Title: Blood-based gene detection of non-small cell lung cancer
Inventor: Hofmann, Schultze, Staratschek-Jox, Wolf, Zander
Applicant: Rheinische Friedrich-Wilhelms-Universität Bonn, Universität zu Köln
State: Pending; Priority date: 02.05.2011
Patent number: US 61/529,476; EP11007082.8
Title: Labeled phosphatases for the screening of inhibitors
Inventor: Rauh, Daniel; Simard, Jeffrey; Waldmann, Herbert
Applicant: Max-Planck-Gesellschaft
Priority date: 31.08.2011
Patent number: EP12153907.6
Title: Novel fusion genes in lung cancer
Inventor: Thomas, Roman; Heuckmann, Johannes; Fischer, Florian; Fernandez-
Cuesta, Lynnette
Applicant: Max-Planck-Gesellschaft
State: Patent application filed and technology in commercial exploitation;
Priority date: 03.02.2012
Genome Network Prostate Cancer
Patent number: DE202009008601.1 (Together with Genome Network Cellular Systems
Genomics)
Title: Inkubationsschale für Hochdurchsatzverfahren bei Protein-Array-Inkubationen
(Gebrauchsmuster)
Inventor: Mannsperger, Schmidt, Korf, Fink, Kameke
Applicant: DKFZ; Metecon GmbH
State: Published; Priority date: 19.06.2009
Patent number: EP09174455.7
Title: Circulating miRNAs as non-invasive markers for diagnosis and staging in
prostate cancer
Inventor: Jan C. Brase, Marc Johannes, Thorsten Schlomm, Maria Fälth, Alexander
Haese, Thomas Steuber, Tim Beissbarth, Ruprecht Kuner, Holger Sültmann
Applicant: DKFZ und Uni Göttingen und Uniklinikum HH-Eppendorf
State: Pending; Priority date: 29.10.2009
Patent number: EP 11162979.6
Title: Epigenetische Marker zur Prostata-Tumor-Diagnostik (Prostate cancer markers)
Inventor: R. Schweiger, H. Lehrach, S. Börno, H. Sültmann, T. Schlomm, G. Sauter
Applicant: Max-Planck-Gesellschaft und DKFZ
State: Submitted; Priority date: 19.04.2011
Genome Network Colon Cancer
Patent number: EP12180459.5
Title: : Biomarkers for colon cancer
Inventor: Schweiger, Michal-Ruth; Grimm, Christina; Herwig, Ralf; Lehrach, Hans
Applicant: Max-Planck-Gesellschaft
Priority date: 14.08.2012
Genome Network Neurodegeneration
Patent number: EP11161325.3
Title: Phenoxazinones or phenothiazones as inhibitors of amyloid formation
Inventor: Wanker, Herbst, Bieschke, Wagner, Wiglenda, Schmidt, Böddrich
Applicant: MDC Berlin
State: Pending; Priority date: 06.04.2011
Genome Network Cellular Systems Genomics
Patent number: DE202009008601.1 (Together with Genome Network Prostate Cancer)
Title: Inkubationsschale für Hochdurchsatzverfahren bei Protein-Array-
Inkubationen (Gebrauchsmuster)
Inventor: Mannsperger, Schmidt, Korf, Fink, Kameke
Applicant: DKFZ; Metecon GmbH
State: Published; Priority date: 19.06.2009
Patent number: EP12154916.6
Title: Biomarker set for identifying a severe form of cancer
Inventor: Korf, Ulrike; Wiemann, Stefan; Bender, Christian; Sonntag, Johanna
Applicant: DKFZ; Priority date: 10.02.2012
Genome Network DiGtoP
Patent number: EP09014709.1, EP09014889.1, US61/264,514, US 61/265,296
Title: Conditional expression of transgenes in vivo
Inventor: L. Schebelle (HMGU), F. Schnütgen (Uni Frankfurt), T. Floss (HMGU)
Applicant: Helmholtz Zentrum München, Uni Frankfurt
State: Pending; Priority date: 25.11.2009; 30.11.2009; 01.12.2009
Patent number: US61/255,621
Title: Homologous recombination in the oocyte
Inventor: Ralf Kühn, Melanie Meyer, Wolfgang Wurst
Applicant: Ralf Kühn, Melanie Meyer, Wolfgang Wurst; Helmholtz Zentrum München
State: Pending; Priority date: 28.10.2009
Patent number: EP10005863.5/ US61/352,103
Title: Fusion proteins comprising a DNA-binding domain of a Tal effector protein and a
nonspecific cleavage domain of a restriction nuclease and their use
Inventor: Kühn, Wurst, Meyer
Applicant: Helmholtz Zentrum München
State: Pending; Priority date: 07.06.2010
Patent number: EP11004637.2
Title: Improved Recombination Efficiency by Inhibition of NHEJ DNA Repair
Inventor: Kühn, Wurst
Applicant: Helmholtz Zentrum München
State: Pending, Priority date: 07.06.2011
Patent number: EP11004635.6
Title: Protein having nuclease activity, fusion proteins and uses thereof
Inventor: Kühn
Applicant: Helmholtz Zentrum München
State: Pending, Priority date: 07.06.2011
Patent number: EP10009584.3; 13/823,431 / 10 009 584.3
Title: HOT1 and uses thereof
Inventor: Dr. D. Kappei, Prof. Dr. F. Buchholz, Prof. Dr. M. Mann, Dr. F. Butter
Applicant: Max-Planck-Innovation GmbH
State: Pending; Priority date: 14.09.2010
Patent number: EP12161060.4/ US 61/814,758 (Together with Genome Network
Obesity)
Title: A novel method of producing an oocyte carrying a modified target sequence in
its genome
Inventor: Kühn, Wurst, Meyer
Applicant: Helmholz Zentrum München
State: Patent application filed and technology in commercial exploitation;
Priority date: 23.03.2012
Patent number: EP131507063.2
Title: Gene editing in the oocyte by Crispr-Cas9 nucleases
Inventor: Kühn, Wurst, Ortiz
Applicant: Helmholtz Zentrum München
State: Pending; Priority date: 15.02.2013
Genome Network Environment-related Diseases
Patent number: PCT/EP2008/008491
Title: Method for identifying an increased susceptibility to ulcerative colitis
Inventor: Schreiber, Franke
Applicant: Universität Kiel
State: Pending, Priority date: 08.10.2008
Patent number: US61/113,342; EP09006623.4-2403
Title: X-chromosomal variation as a diagnostic and therapeutic marker for the
progression to AIDS
Inventor: Siddiqui, Roman; Sauermann, Ulrike; Altmüller, Janine; Nürnberg, Peter;
Fritzer, Elfriede; Nothnagel, Michael; Krawczak, Michael; Platzer, Mathias
Applicant: Deutsches Primatenzentrum GmbH; Leibniz-Institut für Altersforschung
Fritz-Lipmann-Institut e.V.; Universität zu Köln; Christian-Albrechts-Univ. zu Kiel
State: Pending; Priority date: 11.11.2008, 15.05.2009
Innovation Alliance Anti-malarial Agents
Patent number: US61/110,217
Title: Use of inhibitors of host kinases for the treatment of infectious diseases
Inventor: Hannus, Martin, Mota, Prudencio, Rodrigues
Applicant: Cenix BioScience GmbH, Instituto de Medicina Molecular, Faculdade de
Medicina da Universidade de Lisboa
State: Pending; Priority date: 31.10.2008
Innovation Alliance Metabolomic Signatures of Heart Failure
Patent number: US61/299,360; EP10000915.8
Title: Means and methods for diagnosing heart failure in a subject
Inventor: Fuhrmann, Reszka, Kastler, Busch, Leibold, Katus, Frey, Weis, Wolf
Applicant: Metanomics GmbH und Universität Heidelberg
State: Pending; Priority date: 29.01.2010
Innovation Alliance New Tools CVD
Patent number: EP09171773.6
Title: Vasoactive peptide and derivatives thereof
Inventor: Prof. Dr. J. Jankowski, Dr. V. Jankowski, Prof. Dr. W. Zidek, Dr. A. Kretschmer,
Prof. Dr. R. Santos, Prof. Dr. M. van der Giet
Applicant: Bayer Schering Pharma AG, Charité Universitätsmedizin Berlin
State: Pending; Priority date: 30.09.2009
Innovation Alliance WTA Amplification Methods for Biobanks
Patent number: DE102009024143.4
Title: Amplifikation komplexer Nukleinsäuren
Inventor: Korfhage, Fisch
Applicant: Qiagen GmbH
State: Pending; Priority date: 04.06.2009
Download this website as pdf
KTT
MEDIA
CURRENT
NGFN-MEETING-2012
NGFN- MEETING
NGFN1&2
LINKS